Publication: Cow's milk protein allergy: Immunological response in children with cow's milk protein tolerance
Issued Date
2014-01-01
Resource Type
ISSN
22288694
0125877X
0125877X
Other identifier(s)
2-s2.0-84903747234
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.32, No.2 (2014), 171-177
Suggested Citation
Sirasuda Sommanus, Saowanee Kerddonfak, Wasu Kamchaisatian, Soamarat Vilaiyuk, Cherapat Sasisakulporn, Wanlapa Teawsomboonkit, Suwat Benjaponpitak Cow's milk protein allergy: Immunological response in children with cow's milk protein tolerance. Asian Pacific Journal of Allergy and Immunology. Vol.32, No.2 (2014), 171-177. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/34011
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cow's milk protein allergy: Immunological response in children with cow's milk protein tolerance
Other Contributor(s)
Abstract
Objective: To study changes in immunological responses in patients with CMPA during symptomatic and asymptomatic episodes of cow's milk protein tolerance status. Methods: 27 CMPA patients were enrolled and underwent diagnostic evaluation, including CM challenge test, skin prick test and specific IgE to CM. Blood samples were collected in two periods from those who became tolerant (n = 13) and those with persistent CMA (n = 14), in order to measure in vitro PBMC responses to cow's milk protein (IL-10, IFN-γ, IL-5), IgG4 to β- lactoglobulin, casein, BLG-IgG4/IgE ratio and the CAS-IgG4/IgE ratio. Results: Seventy percent of CMPA patients in our study were male with a mean age at diagnosis of 8 months and mean age of onset of 3 months. The reaction time to CM ranged from within 7 minutes to within 14 days. Positive IgEsensitization was defined as either a specific IgE to CM of more than 0.35 kUA/L (N=11) or SPTs positive for CM and/or fresh cow milk (N=20). Forty-eight percent of the patients (n = 13) could tolerate CM by 13.38 months (8 - 19 months). Mean specific-IgE levels to CM were 4.1 kUA/L (range 0.35 - 14.3 kUA/L). Determination of the cytokine (IL-10, IFN-γ, IL-5) response to BLG revealed significantly higher IL-10 levels during the tolerance phase (212.93 vs 142.46 pg/ml, P =.011). There was a significant increase in BLGIgG4 and the BLG-IgG4/IgE ratio in the tolerance phase when compared to the symptomatic phase. Conclusions: IL-10, BLG-IgG4 and the BLGIgG4/ IgE ratio were higher in CMPA patients during the tolerance phase compared to the symptomatic phase.